Diarrhea Clinical Trial
Official title:
Establishing the Optimal Dose of Therapeutic Zinc Supplementation for the Treatment of Acute Diarrhea in Under Five Children - a Dose Response Trial in a South Asian and a Sub-Saharan African Setting
Diarrhoea continues to be a major cause of child deaths. Current treatment of acute watery
diarrhoea includes oral rehydration solution (ORS), zinc and continued feeding. The use of
zinc is based on a number of studies that showed that zinc reduces the duration and severity
of diarrhoea. The recommended dose of zinc in 6-59 month old children is 20mg/day for 10-14
days. This dose is associated with an increased risk of vomiting. No dosing studies are
available to determine the optimal dose of zinc, which while maintaining the benefits also
has a low risk of vomiting.
The investigators will conduct a double-blind randomized controlled trial of three doses of
zinc (20mg/day, 10mg/day and 5mg/day) in two settings - one in Sub-Saharan Africa and the
other in South Asia. The study population will be 4500 children with diarrhoea of less than
72 hours duration who are aged 6-59 months. They will be recruited from outpatient health
facilities. All enrolled children will receive ORS and continued feeding as recommended by
the World Health Organization. Those allocated to the standard zinc dose will receive an oral
dispersible tablet with 20mg zinc daily for 14 days. Those allocated to lower dose zinc will
receive identical tablets with either 10mg or 5mg zinc daily for 14 days. Enrolled children
will be followed by until recovery from diarrhoea or 15 days after enrolment, whichever is
later. In addition, study children will be assessed again at thirty (30), forty-five (45),
and sixty (60) days to estimate impact on post illness outcomes. Primary outcomes will be
mean duration of diarrhoea, proportion of episodes that last longer than 5 days, mean number
of stools and proportion of children with vomiting.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06283784 -
Study To Evaluate The Efficacy of a Proprietary Mix of Live Probiotics In The Prophylaxis Of Diarrhea In Adult Patients
|
N/A | |
| Recruiting |
NCT03851835 -
Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis
|
Phase 3 | |
| Completed |
NCT04003181 -
The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon
|
N/A | |
| Completed |
NCT03596827 -
The Protective Immune Response to Attenuated Enterotoxigenic Escherichia Coli Infection
|
N/A | |
| Recruiting |
NCT05372068 -
Cement flooRs AnD chiLd hEalth (CRADLE)
|
N/A | |
| Completed |
NCT03972618 -
Evaluation of the Efficacy of Sawyer Point One Filters in Schools and Homes in the Dominican Republic
|
N/A | |
| Completed |
NCT05207618 -
Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant
|
N/A | |
| Not yet recruiting |
NCT05052489 -
Registry and Clinical Observation of Children With Diarrhoeal Disease
|
||
| Completed |
NCT02428647 -
Lao Zinc Study: Effects of Two Forms of Daily Preventive Zinc Versus Therapeutic Zinc Supplementation
|
N/A | |
| Completed |
NCT02541695 -
Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli
|
N/A | |
| Completed |
NCT02197780 -
Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD
|
N/A | |
| Completed |
NCT01739231 -
Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults
|
Phase 1/Phase 2 | |
| Completed |
NCT01968408 -
Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children
|
Phase 3 | |
| Completed |
NCT01371656 -
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
|
Phase 3 | |
| Completed |
NCT01438645 -
ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy
|
N/A | |
| Terminated |
NCT01472211 -
Water-based Zinc Intervention Trial in Zinc Deficient Children
|
Phase 0 | |
| Not yet recruiting |
NCT01382199 -
Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients
|
Phase 3 | |
| Terminated |
NCT01048567 -
Efficacy and Safety of Lactobacillus Acidophilus/Rhamnosus Combination for the Prevention of Antibiotic-associated Diarrhea in the Elderly
|
Phase 2 | |
| Completed |
NCT00914225 -
Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya
|
N/A | |
| Completed |
NCT00760851 -
Yogurt Study in Children 2-4 Years Old Attending Daycare
|
Phase 3 |